Reasonable RX - Solving the Drug Price Crisis (Hardcover)

,
A Real Plan for Making Drugs Affordable-and Promoting Innovation, Too "This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making." -Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University "This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all-and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially." -Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration "This book confounds two sets of skeptics: Those who say there's no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say." -Honorable Barney Frank, Congressman from Massachusetts "This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a "must" for insiders of the pharma- and biotech industries." -Dr. Jurgen Drews, retired President of RochePharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How "Not" to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155
Index 177

R302
List Price R340
Save R38 11%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles3020
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

A Real Plan for Making Drugs Affordable-and Promoting Innovation, Too "This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making." -Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University "This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all-and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially." -Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration "This book confounds two sets of skeptics: Those who say there's no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say." -Honorable Barney Frank, Congressman from Massachusetts "This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a "must" for insiders of the pharma- and biotech industries." -Dr. Jurgen Drews, retired President of RochePharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How "Not" to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155
Index 177

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Financial Times Prentice Hall

Country of origin

United States

Release date

2008

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

2008

Authors

,

Dimensions

233 x 161 x 20mm (L x W x T)

Format

Hardcover

Pages

208

ISBN-13

978-0-13-234449-4

Barcode

9780132344494

Categories

LSN

0-13-234449-1



Trending On Loot